GB1051218A - - Google Patents

Info

Publication number
GB1051218A
GB1051218A GB1051218DA GB1051218A GB 1051218 A GB1051218 A GB 1051218A GB 1051218D A GB1051218D A GB 1051218DA GB 1051218 A GB1051218 A GB 1051218A
Authority
GB
United Kingdom
Prior art keywords
formula
hydrogen atoms
pyrimido
symbols
represent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of GB1051218A publication Critical patent/GB1051218A/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB1051218D 1963-03-09 Active GB1051218A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DET0023605 1963-03-09

Publications (1)

Publication Number Publication Date
GB1051218A true GB1051218A (de)

Family

ID=7551073

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1051218D Active GB1051218A (de) 1963-03-09

Country Status (5)

Country Link
CH (1) CH438344A (de)
DE (1) DE1470341C3 (de)
FR (1) FR3713M (de)
GB (1) GB1051218A (de)
IT (1) IT7950418A0 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478833A (en) * 1980-12-27 1984-10-23 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Trisubstituted pyrimido[5,4-d]pyrimidines and salts thereof
EP2062580A1 (de) 2003-04-24 2009-05-27 Boehringer Ingelheim International GmbH Verwendung von Dipyridamol oder Mopidamol zur Behandlung und Prävention thromboembolischer Erkrankungen oder Störungen, die von einer übermäßigen Thrombinbildung und/oder einer erhöhten Expression von Thrombinrezeptoren verursacht werden

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2004201A1 (de) * 1970-01-30 1971-08-05 Thomae Gmbh Dr K Neue 2,6-Bis(dialkanolamino)-pyrimido-[5,4-d]pyrimidine und Verfahren zu ihrer Herstellung
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012118972A2 (en) 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (de) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonisten der guanylatcyclase und deren verwendungen
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
MX2016001714A (es) 2013-08-09 2016-10-03 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478833A (en) * 1980-12-27 1984-10-23 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Trisubstituted pyrimido[5,4-d]pyrimidines and salts thereof
EP2062580A1 (de) 2003-04-24 2009-05-27 Boehringer Ingelheim International GmbH Verwendung von Dipyridamol oder Mopidamol zur Behandlung und Prävention thromboembolischer Erkrankungen oder Störungen, die von einer übermäßigen Thrombinbildung und/oder einer erhöhten Expression von Thrombinrezeptoren verursacht werden

Also Published As

Publication number Publication date
DE1470341C3 (de) 1974-07-04
IT7950418A0 (it) 1979-10-01
CH438344A (de) 1967-06-30
DE1470341A1 (de) 1969-07-03
FR3713M (fr) 1965-11-29
DE1470341B2 (de) 1973-12-06

Similar Documents

Publication Publication Date Title
GB1051218A (de)
GB1321509A (en) Azepine derivatives
GB1392475A (en) Hydrazino-pyrimido-pyridazine derivative
GB1250792A (de)
GB1290174A (de)
GB1108830A (en) Pyrrole- and pyrroline-derivatives
GB1084103A (de)
IE38233L (en) Lysergic acid derivatives
GB1246117A (en) Pharmaceutical preparations containing glucose compounds, glucose derivatives and process for their manufacture
ES342158A1 (es) Procedimiento para la produccion de nuevos 1 - fenoxi-3-al-cohilaminopropanoles-(2) sustituidos.
GB1319841A (en) Quinine alkaloid derivatives
GB1147821A (en) Quinazoline derivatives
GB1260857A (en) IMIDAZO-3H-(4,5-b)-PYRIDINE DERIVATIVES
GB1250353A (de)
ES338693A1 (es) Procedimiento para la preparacion de una composicion fungi-cida.
GB1069716A (en) Improvements in or relating to pyrido[3,4-b]indole derivatives
ES2010855A6 (es) Procedimiento de preparacion de derivados de dioxazocina.
GB1178724A (en) Novel Quaternary Compounds
GB1243955A (en) Novel n-substituted amines and their process of preparation
GB1280887A (en) New isothiocyano-diphenylamines their production and compositions containing same
GB1050249A (de)
GB1027967A (en) Organic nitrates having pharmacological activity
GB1159223A (en) Novel N-Substituted Azabicyclooctanes and -Nonanes and the preparation thereof
GB1049285A (en) Guanidine and dihydroimidazole derivatives
GB1169755A (en) Novel Benzocycloheptathiophene-Ether Derivatives